ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 225 filers reported holding ICU MED INC in Q3 2017. The put-call ratio across all filers is 6.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,868,000 | -35.2% | 31,528 | -29.3% | 0.76% | -48.9% |
| Q1 2020 | $9,053,000 | +67.4% | 44,620 | +54.4% | 1.49% | +163.0% |
| Q4 2019 | $5,408,000 | -6.0% | 28,900 | -19.9% | 0.57% | -5.3% |
| Q3 2019 | $5,755,000 | -58.5% | 36,058 | -34.5% | 0.60% | -56.1% |
| Q2 2019 | $13,867,000 | +0.0% | 55,048 | -5.0% | 1.37% | +1.9% |
| Q1 2019 | $13,862,000 | -4.1% | 57,920 | +12.0% | 1.34% | -6.4% |
| Q4 2018 | $14,451,000 | -21.1% | 51,722 | -1.2% | 1.43% | +2.9% |
| Q3 2018 | $18,308,000 | -4.8% | 52,327 | -19.4% | 1.39% | -2.9% |
| Q2 2018 | $19,223,000 | +14.2% | 64,954 | -1.8% | 1.43% | +8.2% |
| Q1 2018 | $16,829,000 | +68.1% | 66,135 | +42.9% | 1.32% | +89.3% |
| Q4 2017 | $10,014,000 | +14.9% | 46,292 | -1.1% | 0.70% | +9.7% |
| Q3 2017 | $8,712,000 | -20.8% | 46,796 | -26.5% | 0.64% | -22.2% |
| Q2 2017 | $11,000,000 | +23.7% | 63,679 | +9.4% | 0.82% | +34.5% |
| Q1 2017 | $8,895,000 | – | 58,209 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |